Caxton Associates logo

Caxton Associates

North America, New York, United States, New York

Description

Caxton Associates is a New Jersey-based investment management firm providing its services to pooled investment vehicles.

Investor Profile

Caxton Associates has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Caxton Associates frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
MT
North America, California, United States, Los Angeles
Co-Investments: 1
Co-Investments: 1
S
North America, Texas, United States, Amarillo
Co-Investments: 1
Galleon Group
North America, New York, United States, New York
Co-Investments: 1
DC
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Caxton Associates?

Anthera Pharmaceuticals

Hayward, California, United States

Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquitySep 21, 2010
Amount Raised: $31,500,000
Synta Pharmaceuticals

Lexington, Massachusetts, United States

Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJan 14, 2004
Amount Raised: $50,000,000